Advertisement

Suppliers' News

Evonik to expand probiotics portfolio in Asia with Ecobiol®

Evonik is to expand its portfolio in Asia with the probiotic Ecobiol®. It will be launched at VIV Asia in Bangkok. Ecobiol® is designed for the use in aquaculture and poultry production. Ecobiol® helps to maintain the natural gut balance and has a positive effect on the gut microbiome that has been scientifically proven (in-vitro- and in in-vivo).

March 16, 2017

Evonik is to expand its portfolio in Asia with the probiotic Ecobiol®. It will be launched at VIV Asia in Bangkok. Ecobiol® is designed for the use in aquaculture and poultry production. The product was acquired by Evonik from the Spanish company NOREL S.A. in 2016.

Ecobiol® helps to maintain the natural gut balance and has a positive effect on the gut microbiome that has been scientifically proven (in-vitro- and in in-vivo).

“Ecobiol® is new in our portfolio. We are convinced of the product’s high potential and its applicability in various fields by virtue of unique properties”, says Emmanuel Auer, Head of the Animal Nutrition business line at Evonik. “We consider Ecobiol® a key element towards the reduction of antibiotic growth promoters.”

“The product Ecobiol® shows very positive results in both poultry and aquaculture, for instance under various stress conditions. That has been demonstrated in scientific studies as well as in commercial use. For our customers in South East Asia this is of focal interest, particularly in shrimp farming”, says Peter Freisler, Head of Gut Health Solutions.

In addition to the products Fecinor® and Ecobiol® from NOREL S.A., Evonik has recently enlarged its product line with GutCare® PY1, the first own developed probiotic. In January 2017, GutCare® PY1 was introduced in the U.S. market with other countries to follow.

Learn more about Evonik